Evelo Biosciences, Inc. (EVLO)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Oct 6, 2026
Evelo Biosciences Market Cap
Evelo Biosciences has a market cap or net worth of $3.8 thousand as of October 14, 2026. It is the 52,097th most valuable company in the world and the 8,125th biggest in the United States. Its market cap has decreased by 59.99% in one year.
Market Cap
3.80K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,125 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 9, 2018, Evelo Biosciences's market cap has decreased from 517.90M to 3.80K, a decrease of -100.00%. That is a compound annual growth rate of -75.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 3.80K | -59.99% |
| Dec 31, 2025 | 9.49K | - |
| Dec 30, 2024 | 9.49K | -99.19% |
| Dec 29, 2023 | 1.17M | -99.34% |
| Dec 30, 2022 | 176.48M | -45.62% |
| Dec 31, 2021 | 324.50M | -41.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arno Therapeutics | 4.98K |
| Affimed | 4.92K |
| Kaleido Biosciences | 4.26K |
| ONE Bio | 4.19K |
| Baseline Productions | 4.11K |
| Xeno Transplants | 4.04K |
| Synovics Pharmaceuticals | 3.65K |
| Anthera Pharmaceuticals | 3.53K |